Contrasting effects of acute and chronic treatment with imipramine and fluoxetine on inhibitory avoidance and escape responses in mice exposed to the elevated T-maze

Brain Research Bulletin

Volumn 78, Issue 6, 2009, Pages 323-327

  Gomes, Karina Santos ^a,b   de Carvalho Netto, Eduardo Ferreira ^a   Monte, Kátia Cristina Da Silva ^b   Acco, Bruno ^b   Nogueira, Paulo José de Campos ^b   Nunes de Souza, Ricardo Luiz ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Acute and chronic treatment; Antidepressants; Elevated T maze; Escape; Fluoxetine; Imipramine; Inhibitory avoidance; Mice

Indexed keywords

FLUOXETINE; IMIPRAMINE;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; BEHAVIOR CHANGE; CONTROLLED STUDY; DRUG EFFECT; ESCAPE BEHAVIOR; LOCOMOTION; MALE; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-ANXIETY AGENTS; AVOIDANCE LEARNING; ESCAPE REACTION; FLUOXETINE; IMIPRAMINE; MALE; MAZE LEARNING; MICE; MOTOR ACTIVITY; SEROTONIN UPTAKE INHIBITORS;

EID: 58549102958     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2008.11.003     Document Type: Article

References (50)

1. Adamec R.E., and Shallow T. Lasting effects on rodent anxiety of a single exposure to a cat. Physiol. Behav. 54 (1993) 101-109
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (1994), American Psychiatric Association Press, Washington, DC
3. Ballenger J.C. Panic disorder: efficacy of current treatments. Psychopharmacol. Bull. 29 (1993) 477-486
4. Ballenger J.C., Wheadon D.E., Steiner M., Bushnell W., and Gergel I.P. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder. Am. J. Psychiatry 155 (1998) 36-42
5. Beckett S.R.G., Marsden C.A., and Marshal P.W. Intra periaqueductal grey administration of mCPP potentiates a chemically induced defense response. Br. J. Psychopharmacol. 107 (1992) 8P
6. Besret L., Debruyne D., Rioux P., Bonvalot T., Moulin M., Zarifian E., and Baron J.C. A comprehensive investigation of plasma and brain regional pharmacokinetics of imipramine and its metabolites during and after chronic administration in the rat. J. Pharm. Sci. 85 3 (1996) 291-295
7. Blanchard D.C., Griebel G., and Blanchard R.J. Mouse defense behaviors: pharmacological and behavioral assays for anxiety and panic. Neurosci. Biobehav. Rev. 25 (2001) 205-218
8. Blanchard R.J., Griebel G., Henrie J.A., and Blanchard D.C. Differentiation of anxiolytic and panicolytic drugs by effects on rat and mouse defense test batteries. Neurosci. Biobehav. Rev. 21 (1997) 783-789
9. Blanchard R.J., Hebert M.A., Ferrari P., Palanza P., Figueira R., Blanchard D.C., and Parmigiani S. Defensive behaviors in wild and laboratory (Swiss) mice: the mouse defense test battery. Physiol. Behav. 65 (1998) 201-209
10. Bourin M., Baker G.B., and Bradwejn J. Neurobiology of panic disorder. J. Psychosom. Res. 44 (1998) 163-180
11. Carvalho-Netto E.F., and Nunes-de-Souza R.L. Use of elevated T-maze to study anxiety in mice. Behav. Brain Res. 148 (2004) 119-132
12. Daniel W., Adamus A., Melzacka M., Szymura J., and Vetulani J. Cerebral pharmacokinetics of imipramine in rats after single and multiple dosages. Naunyn Schmiedebergs Arch. Pharmacol. 317 3 (1981) 209-213
13. Daniel W., and Melzacka M. A comparative study on desipramine pharmacokinetics in the rat brain after administration of desipramine or imipramine. J. Pharm. Pharmacol. 44 5 (1992) 429-432
14. Fontana D.J., and Commissaris R.L. Effects of acute and chronic imipramine administration on conflict behavior in the rat: a potential "animal model" for the study of panic disorder?. Psychopharmacology 95 (1988) 147-150
15. Gentil V., Lotufo-Neto F., Andrade L., Corda S.T., Bernik M., Ramos R., Maciel L., Miyakawa E., and Gorenstein C. Clomipramine, a better reference drug for panic/agoraphobia. I. Effectiveness comparison with imipramine. J. Psychopharmacol. 7 (1993) 316-324
16. Gillman P.K. Tricyclic antidepressant pharmacology and therapeutic drug interactions updated. Br. J. Pharmacol. 151 6 (2007) 737-748
17. Goldberger E., and Rapoport J. Canine acral lick dermatitis: response to the anti-obsessional drug clomipramine. J. Am. Anim. Hosp. Assoc. 22 (1991) 179-182
18. Graeff F.G. Neurotransmitters in the dorsal periaqueductal grey and animal models of panic anxiety. In: Briley M., and File S.E. (Eds). New Concepts in Anxiety (1991), Macmillan Press, London 288-312
19. Graeff F.G., Ferreira Neto C., and Zangrossi H. The elevated T-maze as an experimental model of anxiety. Neurosci. Biobehav. Rev. 23 (1998) 237-246
20. Graeff F.G., Viana M.B., and Tomaz C. The elevated T maze, a new experimental model of anxiety and memory: Effect of diazepam. Braz. J. Med. Biol. Res. 26 (1993) 67-70
21. Graeff F.G., and Zangossi H. Animal models of anxiety. In: D'haenen H., Den Boer J.A., and Willner P. (Eds). Biological Psychiatry (2002), John Wiley & Sons, New York 1-15
22. Griebel G., Blanchard D.C., Agnes R.S., and Blanchard R.J. Differential modulation of antipredator defensive behavior in Swiss-Webster mice following acute or chronic administration of imipramine and fluoxetine. Psychopharmacology 120 (1995) 57-66
23. Griebel G., Blanchard D.C., and Blanchard R.J. Predator elicited flight responses in the Swiss Webster mice: an experimental model of panic attacks. Prog. Neuropsychopharmacol. Biol. Psychiatry 20 (1996) 185-205
24. Griebel G., Blanchard D.C., Jung A., Lee J.C., Masuda C.K., and Blanchard R.J. Further evidence that the mouse defense test battery is useful for screening anxiolytic and panicolytic drugs: effects of acute and chronic treatment with alprazolam. Neuropharmacology 34 (1995) 1625-1633
25. Handley S.L., and Mithani S. Effects of alpha-adrenorceptor agonist in a maze-exploration model of "fear-motivated behaviour". Naunyn-Scmiedeberg's Arch. Pharmacol. 327 (1984) 1-5
26. Hendrie C.A., and Weiss S.M. The development of an animal model of panic with predictive and face validity. In: Cooper S.J., and Hendrie C.A. (Eds). Ethology and Psychopharmacology (1994), John Wiley & Sons, Chichester 111-132
27. 1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice. Jpn. J. Pharmacol. 68 (1995) 65-70
28. Jardim M.C., Nogueira R.L., Graeff F.G., and Nunes-de-Souza R.L. Evaluation of the elevated T-maze as an animal model of anxiety in the mouse. Brain Res. Bull 48 (1999) 407-411
29. Jenck F., Moreau J.L., and Martin J.R. Dorsal periaqueductal gray-induced aversion as a simulation of panic anxiety: elements of face and predictive validity. Psychiatr. Res. 57 (1995) 181-191
30. Johnson A.L., and File S.E. Yohimbine's anxiogenic action: evidence for noradrenergic and dopaminergic sites. Pharmacol. Biochem. Behav. 32 (1989) 151-156
31. Klein D.F. Delineation of two drug-responsive anxiety syndromes. Psychopharmacology 5 (1964) 397-408
32. Liebowitz M.R. Antidepressants in panic disorder. Br. J. Psychiatry 6 (1989) 46-52
33. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92 (1987) 180-185
34. Nutt D.J. Anxiety and its therapy: today and tomorrow. In: Briley M., and File S.E. (Eds). New Concepts in Anxiety (1991), Macmillan Press, London 1-12
35. Nutt D.J. Overview of diagnosis and drug treatments of anxiety disorders. CNS Spectr. 10 (2005) 49-56
36. Pellow S., Chopin P., File S.E., and Briley M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 14 (1985) 149-167
37. Pinheiro S.H., Zangrossi H., Del-Ben C.M., and Graeff F.G. Elevated mazes as animal models of anxiety: effects of serotonergic agents. An. Acad. Bras. Cienc. 79 1 (2007) 71-85
38. Poltronieri S.C., Zangrossi H., and Viana M.B. Antipanic-like effect of serotonin reuptake inhibitors in the elevated T-maze. Behav. Brain Res. 147 (2003) 185-192
39. Rapoport J.L., Ryland D.H., and Kriete M. Drug treatment of canine acral lick. Arch. Gen. Psychiatry 49 (1992) 517-521
40. Rasmusson A.M., and Charney D.S. Animal models of relevance to PTSD. Ann. NY Acad. Sci. 821 (1997) 333-351
41. Schenberg L.C., Bittencourt A.S., Sudré E.C.M., and Vargas L.C. Modeling panic attacks. Neurosci. Biobehav. Rev. 25 (2001) 647-659
42. Sheehan D.V. Current concepts in the treatment of panic disorder. J. Clin. Psychiatry 60 18 (1999) 16-21
43. Shekhar A., and Di Marco J.A. Defense reaction elicited by injection of GABA antagonists and synthesis inhibitors into the posterior hypothalamus in rats. Neuropharmacology 26 (1987) 407-417
44. Teixeira R.C., Zangrossi H., and Graeff F.G. Behavioral effects of acute and chronic imipramine in the elevated T-maze model of anxiety. Pharmacol. Biochem. Behav. 65 (2000) 571-576
45. Viana M.B., Tomaz C., and Graeff F.G. The elevated T-maze: an animal model of anxiety and memory. Pharmacol. Biochem. Behav. 49 (1994) 549-554
46. Woods A., Smith C., Szewczak M., Dunn R.W., Cornfeldt M., and Corbett R. Selective serotonin re-uptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder. Psychopharmacology 112 2-3 (1993) 195-198
47. Zangrossi H., and File S.E. Chlordiazepoxide reduces the generalized anxiety, but not the direct responses, of rats exposed to cat odor. Pharmacol. Biochem. Behav. 43 (1992) 1195-1200
48. Zangrossi H., and File S.E. Habituation and generalization of phobic responses to cat odor. Brain Res. Bull 33 (1994) 189-194
49. Zangrossi H., and Graeff F.G. A behavioral validation of the elevated T-maze: a new animal model of anxiety. Brain Res. Bull 44 (1997) 1-5
50. Zanoveli J.M., Nogueira R.L., and Zangrossi H. Chronic imipramine treatment sensitizes 5-HT1A and 5-HT2A receptors in the dorsal periaqueductal gray matter: evidence from the elevated T-maze test of anxiety. Behav. Pharmacol. 16 (2005) 543-552